AIDS Treatment News logo      

February 8, 2010

Less resistance with FTC than 3TC when combined with tenofovir

"Amongst patients experiencing a rebound in viral load, those taking 3TC (lamivudine, Epivir) in combination with tenofovir (Viread) were more likely than those taking FTC (emtricitabine, Emtriva) and tenofovir to develop a number of key resistance mutations."

Read more in Aidsmap, February 8, 2010.

0 comments: